Displaying items 1 - 25 of 49 in total
The Health and Disability Commissioner wants answers and a national MP is calling for an inquiry, after four people died following an epilepsy drug brand switch.
A forestry company with close links to New Zealand First has revealed it applied for a $15 million loan from the Provincial Growth Fund, which is overseen by NZ First minister Shane Jones.
A 26-year-old is the fourth person to die shortly after changing from a branded version of the anti-epilepsy drug lamotrigine to a generic version. Video
A forestry company with close links to New Zealand First planned to apply for nearly $100 million under the One Billion Trees programme, which is overseen by the Forestry Minister Shane Jones.
Pharmac has backed down on a controversial drug brand switch affecting patients with epilepsy and mental health conditions after three people died following the change.
A powerful New Zealand First figure helped establish a forestry company that then pushed for money from two key funding streams controlled by a New Zealand First Minister.
Three deaths have been reported to the Centre for Adverse Reactions Monitoring after Pharmac forced patients using the medicine lamotrigine to switch brands.
A woman who fears her daughter's death is linked to a change in her epilepsy medicine is urging vigilance among the 11,000 people being forced to switch drug brands by Pharmac .
A foundation that loans money to NZ First is under scrutiny, with a law professor saying it's lawful but fails to provide the transparency voters need in a democracy.
Land Information Minister and Green MP Eugenie Sage has given a foreign-owned forestry company a free pass to buy thousands of hectares of New Zealand land without applying to the OIO.
Green Rush - The countess breached overseas investment rules while buying an iconic farm station, but was allowed to keep the property and was fined just a fraction of the purchase price. Video
The four largest private landowners in New Zealand are all foreign-owned forestry companies, an RNZ investigation has found.
Vast new pine forests are being hailed as a solution to NZ's carbon emissions deficit - but not all environmentalists see them as a silver bullet and farmers say they could gut rural communities.
Green Rush - Forestry Minister Shane Jones is considering reining in conversions of farmland to forestry after a rural backlash. Video
The former prime minister could be forced to stand down from one of his banking roles because of a potential conflict of interest. Audio
People with epilepsy say their lives are being turned upside down by seizures after Pharmac switched their medicines in a cost savings drive. Warning: Graphic images.
Yesterday smoking researcher Marewa Glover told MPs that children could heal from exposure to smoking in cars. But perhaps most controversial is the source of $1.5m of her research funding - tobacco… Audio
The tobacco giant tried to gain access to an Auckland poverty group as well as a South Auckland DHB in a bid to get its new tobacco products marketed to poor people.
A tobacco company is targeting Māori with its new e-cigarette because it wants to make money and not because it's concerned about public health, Associate Health Minister Jenny Salesa says.
Smoke and Mirrors - Philip Morris is visiting marae and sports clubs to offer free trials and discounts on its e-cigarette as it targets Māori. Guyon Espiner investigates. Video
Smoke and Mirrors - A US vaping product, which is so popular with young people it's under fire by the FDA, is coming to NZ. Guyon Espiner reports.
Desperate patients are being left in the dark as to when Pharmac will fund medicines. Guyon Espiner asks why the drug-buying agency operates with such secrecy. Video
Guyon Espiner reveals how lung cancer patients are buying cut-price drugs from India, as other Kiwis fundraise, petition and apply for clinical trials to access medications Pharmac won't fund.
Pharmac is making 10,000 people with epilepsy change medication, despite Medsafe's opposition the move. Guyon Espiner asks why it carries out up to 60 drug switches a year.
An endocrinologist says New Zealand's type 2 diabetes drugs are 'third world'. Guyon Espiner asks why Pharmac won't fund the medicines experts want.